Medicine & Life Sciences
Perindopril
100%
Cost-Benefit Analysis
59%
Blood Pressure
44%
Costs and Cost Analysis
43%
Quality-Adjusted Life Years
38%
Economics
26%
Hospital Costs
26%
Stroke
23%
England
23%
sorbitan monolaurate
18%
Bed Occupancy
18%
Secondary Care Centers
18%
Indapamide
17%
National Institutes of Health (U.S.)
12%
Cerebrovascular Disorders
12%
Insurance Benefits
11%
Health Care Costs
10%
Cause of Death
9%
Primary Health Care
9%
Length of Stay
8%
Clinical Studies
8%
Health Care Outcome Assessment
7%
Databases
6%
Health
5%
Therapeutics
1%
Business & Economics
Blood Pressure
99%
Economic Evaluation
74%
Quality-adjusted Life Years
47%
Costs
26%
Bed Occupancy
18%
Health State
15%
Primary Care
15%
England
15%
Medical Costs
15%
Hospital Costs
14%
Length of Stay
13%
Resource Utilization
13%
Health Benefits
13%
Analytical Model
12%
Economic Consequences
12%
Excellence
10%
Economic Analysis
10%
Data Base
10%
Guidance
10%
Economic Impact
10%
Health
7%
Social Sciences
blood pressure
87%
costs
39%
event
39%
evaluation
31%
life years
30%
economics
29%
stroke
26%
health
10%
cause
9%
cause of death
8%
economic impact
8%
utilization
6%
time
5%
resources
3%